Characterization of a Saporin Mitotoxin Specifically Cytotoxic to Cells Bearing the Granulocyte-Macrophage Colony-Stimulating Factor Receptor

References

• Bacha P., Murphy J. R., Reichlin S. Thyrotropin-releasing hormone-diphtheria toxin-related polypeptide conjugates. J. Biol. Chem. 1983; 258: 1565–1569
   PubMed Web of Science ®Google Scholar
• Bergamaschi G., Cazzola M., Dezza L., Sevino E., Consonni L., Lappi D. A. Killing of K562 cells with conjugates between human transferrin and a ribosome-inactivating protein (SO-6). Brit. J. Heamat. 1988; 68: 379–384
   PubMed Web of Science ®Google Scholar
• Bregni M., Lappi D. A., Siena S., Formosa A., Villa S., Soria M., Bonadonna G., Gianni A. M. Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cells. J. Natl Cancer. Inst. 1988; 80: 511–517
   PubMedGoogle Scholar
• Brizzi M. F., Avanzi G. C., Veglia F., Clark S. C., Pegoraro L. Expression and modulation of IL-3 and GM-CSF receptors in human growth factor dependent leukaemic cells. Brit. J. Haemat. 1990; 76: 203–209
   PubMed Web of Science ®Google Scholar
• Burgess A. W., Begley C. G., Johnson G. R., Lopez A. F., Williamson D. J., Mermod J. J., Simpson R. J., Schmitz A., DeLamarter J. F. Purification and properties of bacteri-ally synthesized human granulocyte-macrophage colony stimulating factor. Blood 1987; 69: 43–51
   PubMed Web of Science ®Google Scholar
• Bussolino F., Wang J. M., Defilippi P., Turrini F., Sanavio F., Edgell C.-J., Aglietti M., Arese P., Mantovani A. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989; 337: 471–473
   PubMed Web of Science ®Google Scholar
• Case J. P., Lorberboum-Galski H., Lafyatis R., FitzGerald D., Wilder R., Pastan I. Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats. Proc. Natl Acad. Sci. USA 1989; 86: 287–291
   PubMed Web of Science ®Google Scholar
• Chaudhary V. J., Fitzgerald D. J., Adhya S., Pastan I. Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxin. Proc. Natl Acad. Sci. USA 1987; 84: 4538–4542
   PubMed Web of Science ®Google Scholar
• Cozzolino F., Torcia M., Bettoni S., Aldinucci D., Burgio V. L., Petti M. C., Rubartelli A., Barbui T., Rambaldi A. Interleukin-1 and interleukin-2 control granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia. Int. J. Cancer 1990; 46: 902–907
   PubMed Web of Science ®Google Scholar
• Davis L., Dibner M., Battey J. F. Basic Methods in Molecular Biology. Elsevier Science Publishing Co., New York 1986
   Google Scholar
• Di Persio J., Billing P., Kaufman S., Eghtesady P., Williams R. E., Gasson J. E. Characterization of the human granulocyte-macrophage colony-stimulating factor receptor. J. Biol. Chem. 1988; 263: 1834–1841
   PubMedGoogle Scholar
• Gasson J. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 1991; 77: 1131–1145
   PubMed Web of Science ®Google Scholar
• Gelfi C., Bossi M. L., Bjellqvist B., Righetti P. G. Isoelectric focusing in immobilized pH gradients in the pH 10–11 range. J. Biochem. Biophys. Meth. 1987; 15: 41–48
   PubMedGoogle Scholar
• Herschman H. R., Simpson D. L., Cawley D. B. Toxic Ligand Conjugates as Tools in the Study of Receptor-Ligand Interactions. J. Cell. Biochem. 1982; 20: 163–176
   PubMed Web of Science ®Google Scholar
• Kitamura T., Hayashida K., Sakamaki K., Yokota T., Arai K.-I., Miyajima A. Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF): Evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor. Proc. Natl Acad. Sci. USA 1991; 88: 5082–5086
   PubMed Web of Science ®Google Scholar
• Lappi D. A., Baird A. Mitotoxins: growth factor-targeted cytotoxic molecules. Prog. Growth Factor Res. 1991; 2: 223–236
   Google Scholar
• Lappi D. A., Esch F. S., Barbieri L., Stirpe F., Soria M. Characterization of a Saponaria officinalis seed ribosome-inactivating protein: immunoreactivity and sequence homologies. Biochem. Biophys. Res. Commun. 1985; 129: 934–942
   PubMedGoogle Scholar
• Lappi D. A., Maher P. A., Martineau D., Baird A. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor. J. Cell. Physiol. 1991; 147: 17–26
   PubMed Web of Science ®Google Scholar
• Lappi D. A., Martineau D., Baird A. Biological and chemical characterization of basic FGF-saporin mitotoxin. Biochem. Biophys. Res. Commun. 1989; 160: 917–923
   PubMed Web of Science ®Google Scholar
• Lappi D. A., Martineau D., Maher P. A., Florkiewicz R. Z., Buscaglia M., Gonzalez A. M., Farris J., Hamer M., Fox R., Baird A. Basic fibroblast growth factor in cells derived from Dupuytren's contracture: Synthesis, presence and implications for treatment of the disease. J. Hand Surg. 1992; 17A: 324–332
   Google Scholar
• Lorberboum-Galski H., Barrett L. V., Kirkman R. L., Ogata M., Willingham M. C., Fitzgerald D. J., Pastan I. Cardiac allograft survival in mice treated with IL-2PE40. Proc. Natl Acad. Sci. USA 1989; 86: 1008–1012
   PubMed Web of Science ®Google Scholar
• Lorberboum-Galski H., Kozak R. W., Waldmann T. A., Bailon P., Fitzgerald D. J., Pastan I. Interleukin-2 (IL2) PE40 is cytotoxic to cells /playing either the p55 or p70 subunit of the IL2 receptor. J. Biol. Chem. 1988; 263: 18650–18656
   PubMed Web of Science ®Google Scholar
• Lusis A. J., Koeffler H. P. Action of granulocyte-macrophage colony-stimulating factors: studies using a human leukemia cell line. Proc. Natl Acad. Sci. USA 1980; 77: 5346–5350
   PubMedGoogle Scholar
• Marcucci F., Lappi D. A., Ghislieri M., Martineau D., Siena S., Bregni M., Soria M., Gianni A. M. In vivo effects in mice of an anti-T cell immunotoxin. J. Immunol. 1989; 142: 2955–2960
   PubMedGoogle Scholar
• Nicola H. A., Peterson L., Hilton D. J., Metcalf D. Cellular processing of murine colony-stimulating factor (multi-CSF, GM-CSF, G-CSF) receptors by normal hematopoietic cells and cell lines. Growth Factors 1988; 1: 41–49
   PubMedGoogle Scholar
• Pai L. H., Gallo M. G., Fitzgerald D. J., Pastan I. Antitumor activity of a transforming growth factor α-Pseudomonas exotoxin fusion protein (TGF-α-PE40). Cancer Res. 1991; 51: 2808–2812
   PubMed Web of Science ®Google Scholar
• Pastan I., FitzGerald D. Pseudomoms exotoxin: Chi-meric toxins. J. Biol. Chem. 1989; 264: 15157–15160
   PubMed Web of Science ®Google Scholar
• Pastan I., Willingham M. C., FitzGerald D. J. P. Immunotoxins. Cell 1986; 47: 641–648
   PubMed Web of Science ®Google Scholar
• Pun R. K., Ogata M., Leland P., Feldman G. M., FitzGerald D., Pastan I. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cy-totoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin. Cancer Res. 1991; 51: 3011–3017
   PubMedGoogle Scholar
• Schrimsher J. L., Rose K., Simona M. G., Wingfield P. Characterization of human and mouse granulocyte-cacrophage-colony-stimulating factors derived from Escherichia coli. Biochem. J. 1987; 247: 195–199
   PubMedGoogle Scholar
• Schwartz J., Penke B., Rivier J., Vale W. A new cytotoxin specific for the target cells of corticotropin-releasing factor. Endocrinology 1987; 121: 1454–1460
   PubMed Web of Science ®Google Scholar
• Siegall C. B., Kreitman R. J., Fitzgerald D. J., Pastan I. Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice. Cancer Res. 1991; 51: 2831–2836
   PubMed Web of Science ®Google Scholar
• Siena S., Bregni M., Formosa A., Martineau D., Lappi D. A., Bonadonna G., Gianni A. M. Evaluation of anti-human T-lymphocyte saporin immunotoxins potentially useful in human transplantation. Transplantation 1988a; 46: 747–753
   PubMedGoogle Scholar
• Siena S., Lappi D. A., Bregni M., Formosa A., Villa S., Soria M., Bonadonna G., Gianni A. M. Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKTI-SAP) with in vivo stability into nonhuman primates. Blood 1988b; 72: 756–765
   PubMed Web of Science ®Google Scholar
• Stirpe F., Barbieri L. Ribosome-inactivating proteins up to date. FEBS Leffers 1986; 195: 1–8
   PubMed Web of Science ®Google Scholar
• Shrpe F., Gasperi-Campani A., Barbieri L., Falasca A., Abbon-Danza A., Stevens W. A. Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (com cockle) and of Asparagus officinalis L (asparagus), and from the latex of Hura crepitans L. (sandbox tree). Biochem. J. 1983; 216: 617–625
   PubMedGoogle Scholar
• Williamson D. J., Begley C. G., Vadas M. A., Metcalf D. The detection and initial characterization of colony-stimulating factors in synovial fluid. Clin. Exp. Immunol. 1988; 72: 67–73
   PubMedGoogle Scholar
• Wong G. G., Witek J. S., Temple P. A., Wilkens K. M., Leary A. C., Luxenberg D. P., Jones S. S., Brown E. L., Kay R. M., Orr E. Z., Shoemaker C., Golde D. W., Kaufman R. J., Hewick R. M., Wang E. A., Clark S. C. Human GM-CSF: Molecular doning of the complementary DNA and purification of the natural and recombinant proteins. Science 1985; 228: 810–815
   PubMed Web of Science ®Google Scholar
• Xu W. D., Firestein G. S., Taetle R., Kaushansky K., Zvaifler N. J. Cytokmes in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J. Clin. Invest. 1989; 83: 876–882
   PubMed Web of Science ®Google Scholar